Collagen I in the hip capsule plays a role in postoperative clinical function in patients with developmental dysplasia of the hip

doi:10.21203/rs.3.rs-19896/v1

Download PDF

Research article

Collagen I in the hip capsule plays a role in postoperative clinical function in patients with developmental dysplasia of the hip

https://doi.org/10.21203/rs.3.rs-19896/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this older preprint version

Read the latest preprint version →

Purpose The aims of the present study is to evaluate the roles of collagen I and III in the hip capsule in the postoperative clinical function of patients with developmental dysplasia of the hip (DDH).

Methods Hip capsules from 155 hips of 120 patients were collected during surgery. The patients were divided into three groups according to age: I: 2–3.5 years; II: 3.5–5 years; and III: 5–6 years. Patient clinical function and radiographic outcomes were evaluated with the McKay scores and Severin classification. The expression of collagen I and III was detected through immunohistochemistry and quantitative RT-PCR and analysed according to age, sex, degree of dislocation and McKay classification. All patients received similar operations and achieved good results on the basis of postoperative X-ray imaging.

Results The average follow-up time was 3.4 years (range 2–4.3 years). There were no changes in the expression of collagen III in the different groups. The expression of collagen I according to age and sex was not significantly different. Lower expression of collagen I was observed in DDH patients with a higher degree of dislocation according to the Tonnis grade. The highest expression of collagen I was detected in the group with poor clinical function according to the McKay classification.

Conclusion Collagen I is correlated with the degree of dislocation and is a risk factor for poor clinical function in DDH patients. Collagen I is correlated with the degree of hip dislocation and poor clinical function in DDH patients.

Orthopedics

Orthopedic Surgery

Developmental dysplasia of the Hip

Collagen I

Hip capsule

Joint function

surgery

Developmental dysplasia of the hip (DDH) is one of the most common deformities in children (1–3). Pathological changes in the acetabulum, proximal femur, and joint capsule have been observed (4, 5). During DDH treatment, the bone deformities are corrected, and the capsule is partly removed and tightened (5, 6). Bone changes can be detected by X-ray imaging; however, the molecular changes in the hip joint capsule are still unknown.

The joint capsule is mainly composed of collagen and a small number of fibroblasts (7, 8). The major collagens in the capsule are types I and III, with the former making up 83% of the collagen present (9). Collagen type I is located in tissues that require high levels of mechanical strength, and it is abundant at sites where new fibrosis and connective tissue proliferation occur (10, 11). Collagen type III is involved in the development and differentiation of mesenchymal tissue, and it is present in large quantities in tissues that require high levels of mechanical compliance (11, 12). Determination of the expression of collagen types I and III is valuable for assessing whether changes in the joint capsule indicate the development of arthrochalasis (13). Children with DDH generally experience different degrees of joint laxity (14, 15). However, the changes in collagen types I and III in DDH capsules and their relation to clinical manifestations remain unknown.

To investigate the changes in collagen types I and III in DDH capsules, we retained DDH capsule specimens during surgery. The expression of collagen I and III in the specimens was detected by immunohistochemistry and quantitative (q)RT-PCR. We also investigated the relationship between the expression of collagen I and III and the degree of hip dislocation and function. To the best of our knowledge, this is the first study to detect the relationship between DDH capsules and clinical manifestations.

Patients and materials

We enrolled 128 children > 2 years of age with DDH diagnosed between March 2014 and June 2016. We excluded eight patients with poor results during follow-up X-ray imaging which may interfere the evaluation of clinical function. In the remaining 120 patients (155 hips), the mean age was 4.6 years (range 2–6 years); 95 patients with 125 hips were female, and 25 patients with 30 hips were male; 85 cases presented with unilateral DDH and 35 with bilateral; 98 specimens were from the left side and 57 from the right side. The patients were divided into three groups according to age: I: 2–3.5 years; II: 3.5–5 years; and III: 5–6 years. The degree of dislocation was evaluated with Tonnis’ classification (16, 17) before surgery. The study was approved by the Ethical Committee of Anhui Provincial Children’s Hospital. Verbal consent was obtained from the legal guardian of the children.

Clinical data collection

All the patients received open reduction and pelvic osteotomy and/or femoral shortening osteotomy from two senior paediatric orthopaedists. The hip capsules were collected for immunohistochemistry and qRT-PCR. The patients received half hip cast immobilization for 6 weeks followed by physical therapy. The average follow-up time was 3.4 years (range 2–4.3 years). The clinical function and radiographic outcomes at the last follow-up were evaluated with McKay’s scoring system and the Severin classification, respectively (18, 19).

Immunohistochemistry

The capsules isolated from DDH hips were fixed in 4% paraformaldehyde and embedded in paraffin. Five representative sections (4 µm) from each joint capsule obtained from various depths were mounted on slides. The sections were deparaffinized in xylene, rehydrated, and washed three times with phosphate buffered saline for 5 min each at room temperature. Endogenous peroxidase activity was blocked by 3% hydrogen peroxide for 10 min. The slides were subjected to antigen retrieval by microwave irradiation in 10 mM sodium citrate (pH 6.0) for 10 min. Sections were incubated overnight at 4 °C with either monoclonal rabbit anti-human collagen I or rabbit anti-human collagen III antibody (Abcam, Cambridge, MA, USA) at a dilution of 1:200. In the negative control reaction, the primary antibody was omitted. Thereafter, sections were analysed with an EnvisionTM Detection Kit (Dako, Glostrup, Denmark), treated with 3,3′-diaminobenzidine and counterstained with Mayer’s haematoxylin. Slides were visualized under a microscope. The integrated optical density was measured in 5 randomly chosen regions of each section using Image Pro Plus.

RNA extraction and qRT-PCR

Total RNA was extracted from the capsules using TRIzol reagent (Invitrogen Life Technologies, Paisley, UK). The purity and amount of RNA were determined by measuring the OD_260/280 ratio. Preservation of 28S and 18S rRNA was used to assess RNA integrity.

Reverse transcription of 1 µg RNA to cDNA was performed using a ReverTra Ace qPCR RT kit (TOYOBO, Osaka, Japan). The yields were quantified spectrophotometrically. qRT-PCR was performed using 5 µl cDNA (100 ng), 2 µl each primer (10 µM), 25 µl SYBR Green Realtime PCR Master Mix (TOYOBO), and 16 µl water in a total volume of 50 µl. The target genes were Collagen I and Collagen III, whose expressions were normalized to that of the housekeeping gene β-actin. The primers are shown in Table 2. qRT-PCR was performed using an ABI PRISM 3730HT Sequence Detection System (Vernon, CA, USA), which was programmed to an initial step of 10 min at 95 °C for polymerase activity, followed by 40 cycles of 15 s denaturation at 95 °C, 15 s annealing at 60 °C, and 45 s extension at 72 °C. The absence of nonspecific PCR products was verified using melting curve and electrophoresis analyses. Reactions were performed in triplicate, and the average values were used. The relative quantification of target genes was determined using the ΔΔCT method. The results are expressed as the fold change in expression of the target gene relative to that of the housekeeping gene.

Statistical analysis

Descriptive statistical analysis was performed using mean values and standard deviations. Data were analysed with the statistical software SPSS 16.0, and two-tailed Student’s t tests were used. P < 0.05 was considered statistically significant.

Clinical data and follow-up results

One hundred and twenty patients (150 hips) were followed up and evaluated on the basis of X-ray imaging and clinical function. The radiographic results were excellent or good. Clinical data and McKay’s classification results are shown in Table 1. The patients were divided into three groups according to Tonnis’ classification and their preoperative X-ray films: 24 hips were Tonnis I and II, 48 were Tonnis III, and 83 were Tonnis IV (Table 1).

Expression of collagen I and III in different basic clinical groups

Immunohistochemistry and qRT-PCR showed the same trends in variation in the different groups. There was no significant difference in the expression of collagen I and III according to age group, sex, left and right side, or unilateral and bilateral DDH (P > 0.05).

Expression of collagen I and III according to degree of dislocation

To investigate the relationship between collagen I and III and the degree of dislocation, we divided the patients into three groups according to the Tonnis classification. There were only three hips in Tonnis class I, so Tonnis classes I and II were analysed as a single group. For collagen III, there were no significant differences among the three classification groups. However, significantly lower expression of collagen I was observed in the Tonnis IV group through immunohistochemistry (Fig. 1A-D) and qRT-PCR compared to the other two groups (P < 0.05) (Fig. 3A).

Expression of collagen I and III according to McKay’s classification

There was no significant difference in the expression of collagen III as measured by immunohistochemistry and qRT-PCR. However, significantly higher expression of collagen I was observed in patients with poorer joint function compared to the other two groups (P < 0.001). (Fig. 2A-E) (Fig. 3B)

DDH is one of the most common lower limb deformities (1, 2, 20). It is characterized by multiple pathological changes, including in the acetabulum, proximal femur, and soft tissue around the hip (4, 21). Although the DDH capsules are tightened during surgery (4, 5, 22, 23), some patients still have poor clinical function (24). In the present study, all patients underwent similar surgery and physical therapy performed by two senior paediatric orthopaedists and the same physical therapist, respectively. Some patients continued to have poor clinical function of the hip. The capsule factors may be of concern. The main components of capsular collagen I and III were detected and analysed among the different groups according to different factors.

The major types of collagen in the hip joint capsule are I and III(9, 25). Three variations in the COL1A1 gene promoter have been reported in patients with DDH, and a higher rate of total variation in the COL1A1 gene contributes to DDH (26). Skirving et al. (27) reported that the ratio of collagen I and III changes in the joint capsule in children with DDH compared with normal children. Hagiwara et al. (28) fixed the knees of rats and detected the expression of collagen I and III at different stages. They found no changes in the expression of collagen I and III or in acquired ankylosis. These studies show that collagen I is important for resistance to tension in the joint capsule. The changes in collagen may result in differing degrees of joint laxity in DDH.

Age and sex are factors that influence the clinical function of the hip joint (22, 29). Male patients often have poorer function than female patients (4, 30). One study showed that sex is an independent factor with a smaller contribution than age to passive stiffness of the hip capsule ligaments (31). In the present study, all of the patients were at a good age for surgery. There were no significant differences among the patients by age or sex. Our patients were all under 6 years of age, and their clinical function was good to excellent for their age. Collagen I and III did not change with age. Our results suggest that collagen I and III in the hip joint capsule may not be correlated with joint function among patients of different ages and sexes.

The degree of joint dislocation is an important risk factor for a poor prognosis of DDH (4, 30), and many studies have shown that a high degree of dislocation results in poor clinical outcomes (19, 30, 32). However, patients under 6 years of age with a high degree of hip dislocation have been found to achieve good results after a one-stage operation with pelvic osteotomy, femur shortening, and capsulorrhaphy (4, 30). Clinical outcomes can be improved by the implementation of surgical techniques in some patients with a high degree of hip dislocation (4, 33). However, there are still some patients who have poor clinical results (4, 34, 35). We speculated that capsule factors may play a role in clinical outcome. Our patients were divided into three groups according to Tonnis grade, and the expression of collagen I and III was analysed in these different groups. The expression of collagen III did not differ among the groups. However, a lower expression of collagen I was observed in patients with a higher degree of dislocation. The results suggest that collagen I is related to the degree of dislocation in DDH patients. A lower expression of collagen I may lead to joint laxity and a subsequently higher degree of dislocation.

The clinical function of DDH is one of the main evaluation criteria for successful treatment. DDH risk factors include age, degree of dislocation, and AVN (4, 30). Some studies have shown that joint laxity is beneficial for clinical function in DDH (14, 36). Joint laxity may be correlated with the expression of collagen in the hip joint capsule. In the present study, the patients were divided into three groups according to McKay’s classification. The expression of collagen III showed no differences among the three classification groups. However, a higher expression of collagen I was observed in the classification group with poor McKay scores. Given that collagen I is associated with DDH and capsule laxity, the higher expression of collagen I in the present study might have resulted in less capsular laxity, which might have led to poor postoperative clinical function of hip joints in patients with DDH. Our results suggest that collagen I plays an important role in the clinical function of DDH.

There were limitations in the present study. First, we need more useful clinical scoring criteria than the McKay classification to evaluate the outcomes of clinical function of the hip. All patients need further and longer follow-up, even up to skeletal maturity, to confirm the ultimate clinical and radiographic outcomes. Further research on the relation between collagen I and the clinical function of postoperative DDH patients will be conducted.

In summary, differences in the expression of collagen I and III were not observed in DDH patients of different ages and sexes. Collagen I is correlated with the degree of hip dislocation and poor clinical function in DDH patients.

Ethics approval and consent to participate: The study was approved by the Ethical Committee of Anhui Provincial Children’s Hospital. Verbal consent was obtained from the legal guardian of the children because there was no harm to the participant during the study. We documented the main consent of the study, including that the study would not change any outcome of the treatment, and opened the patient’s private material to anyone.
Consent for publication: Not applicable
Availability of data and material: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Competing interests: The authors declare that they have no competing interests.
Funding: This work was supported by the Natural Science Foundation of Anhui Province, China (project no. 1408085QH153). The role of the funding body was to provide the research funding for the study.
Authors' contributions: BN wrote the manuscript and analysed the data; SZ performed the experiment; JS analysed the data and performed the operation. All authors have read and approved the final manuscript.
Acknowledgements: Not applicable.

Stein-Zamir C, Volovik I, Rishpon S, Sabi R. Developmental dysplasia of the hip: risk markers, clinical screening and outcome. Pediatrics international : official journal of the Japan Pediatric Society2008 Jun;50(3):341-5.
Sharpe P, Mulpuri K, Chan A, Cundy PJ. Differences in risk factors between early and late diagnosed developmental dysplasia of the hip. Archives of disease in childhood Fetal and neonatal edition2006 May;91(3):F158-62.
Patel H, Canadian Task Force on Preventive Health C. Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2001 Jun 12;164(12):1669-77.
Ning B, Yuan Y, Yao J, Zhang S, Sun J. Analyses of outcomes of one-stage operation for treatment of late-diagnosed developmental dislocation of the hip: 864 hips followed for 3.2 to 8.9 years. BMC musculoskeletal disorders2014 Nov 28;15:401.
Wedge JH, Kelley SP. Strategies to improve outcomes from operative childhood management of DDH. The Orthopedic clinics of North America2012 Jul;43(3):291-9.
Klein C, Fontanarosa A, Khouri N, Bellity J, Padovani JP, Glorion C, Wicart P. Anterior and lateral overcoverage after triple pelvic osteotomy in childhood for developmental dislocation of the hip with acetabular dysplasia: Frequency, features, and medium-term clinical impact. Orthopaedics & traumatology, surgery & research : OTSR2018 May;104(3):383-7.
Kleftogiannis F, Handley CJ, Campbell MA. Characterization of extracellular matrix macromolecules from bovine synovial capsule. Journal of orthopaedic research : official publication of the Orthopaedic Research Society1994 May;12(3):365-74.
Wess TJ. Collagen fibril form and function. Advances in protein chemistry2005;70:341-74.
Montes GS. Structural biology of the fibres of the collagenous and elastic systems. Cell biology international1996 Jan;20(1):15-27.
Hulmes DJ. Building collagen molecules, fibrils, and suprafibrillar structures. Journal of structural biology2002 Jan-Feb;137(1-2):2-10.
Brodsky B, Persikov AV. Molecular structure of the collagen triple helix. Advances in protein chemistry2005;70:301-39.
Ricard-Blum S, Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathologie-biologie2005 Sep;53(7):430-42.
Ito S, Matsumoto T, Enomoto H, Shindo H. Histological analysis and biological effects of granulation tissue around loosened hip prostheses in the development of osteolysis. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association2004;9(5):478-87.
Olshan AF, Schroeder JC, Alderman BW, Mosca VS. Joint laxity and the risk of clubfoot. Birth defects research Part A, Clinical and molecular teratology2003 Aug;67(8):585-90.
Luft M. Pediatric orthopedics in clinical practice. Orthopedics1984 Jun;7(6):948.
Tonnis D. Surgical treatment of congenital dislocation of the hip. Clinical orthopaedics and related research1990 Sep(258):33-40.
Narayanan U, Mulpuri K, Sankar WN, Clarke NM, Hosalkar H, Price CT, International Hip Dysplasia I. Reliability of a New Radiographic Classification for Developmental Dysplasia of the Hip. Journal of pediatric orthopedics2015 Jul-Aug;35(5):478-84.
McKay DW. A comparison of the innominate and the pericapsular osteotomy in the treatment of congenital dislocation of the hip. Clinical orthopaedics and related research1974 Jan-Feb(98):124-32.
Ahmed E, Mohamed AH, Wael H. Surgical treatment of the late - presenting developmental dislocation of the hip after walking age. Acta ortopedica brasileira2013;21(5):276-80.
Talbot C, Adam J, Paton R. Late presentation of developmental dysplasia of the hip : a 15-year observational study. The bone & joint journal2017 Sep;99-B(9):1250-5.
Giorgi M, Carriero A, Shefelbine SJ, Nowlan NC. Effects of normal and abnormal loading conditions on morphogenesis of the prenatal hip joint: application to hip dysplasia. Journal of biomechanics2015 Sep 18;48(12):3390-7.
Wang TM, Wu KW, Shih SF, Huang SC, Kuo KN. Outcomes of open reduction for developmental dysplasia of the hip: does bilateral dysplasia have a poorer outcome? The Journal of bone and joint surgery American volume2013 Jun 19;95(12):1081-6.
Pollet V, Van Dijk L, Reijman M, Castelein RMC, Sakkers RJB. Long-term outcomes following the medial approach for open reduction of the hip in children with developmental dysplasia. The bone & joint journal2018 Jun 1;100-B(6):822-7.
Ozkut AT, Iyetin Y, Unal OK, Soylemez MS, Uygur E, Esenkaya I. Radiological and clinical outcomes of medial approach open reduction by using two intervals in developmental dysplasia of the hip. Acta orthopaedica et traumatologica turcica2018 Mar;52(2):81-6.
Akilbekova D, Bratlie KM. Quantitative Characterization of Collagen in the Fibrotic Capsule Surrounding Implanted Polymeric Microparticles through Second Harmonic Generation Imaging. PloS one2015;10(6):e0130386.
Zhao L, Tian W, Pan H, Zhu X, Wang J, Cheng Z, Cheng L, Ma X, Wang B. Variations of the COL1A1 gene promoter and the relation to developmental dysplasia of the hip. Genetic testing and molecular biomarkers2013 Nov;17(11):840-3.
Skirving AP, Sims TJ, Bailey AJ. Congenital dislocation of the hip: a possible inborn error of collagen metabolism. Journal of inherited metabolic disease1984;7(1):27-31.
Hagiwara Y, Ando A, Onoda Y, Matsui H, Chimoto E, Suda H, Itoi E. Expression patterns of collagen types I and III in the capsule of a rat knee contracture model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society2010 Mar;28(3):315-21.
Akgul T, Bora Goksan S, Bilgili F, Valiyev N, Hurmeydan OM. Radiological results of modified Dega osteotomy in Tonnis grade 3 and 4 developmental dysplasia of the hip. Journal of pediatric orthopedics Part B2014 Jul;23(4):333-8.
Sankar WN, Young CR, Lin AG, Crow SA, Baldwin KD, Moseley CF. Risk factors for failure after open reduction for DDH: a matched cohort analysis. Journal of pediatric orthopedics2011 Apr-May;31(3):232-9.
Pieroh P, Schneider S, Lingslebe U, Sichting F, Wolfskampf T, Josten C, Bohme J, Hammer N, Steinke H. The Stress-Strain Data of the Hip Capsule Ligaments Are Gender and Side Independent Suggesting a Smaller Contribution to Passive Stiffness. PloS one2016;11(9):e0163306.
Forlin E, Munhoz da Cunha LA, Figueiredo DC. Treatment of developmental dysplasia of the hip after walking age with open reduction, femoral shortening, and acetabular osteotomy. The Orthopedic clinics of North America2006 Apr;37(2):149-60, vi.
Ganger R, Radler C, Petje G, Manner HM, Kriegs-Au G, Grill F. Treatment options for developmental dislocation of the hip after walking age. Journal of pediatric orthopedics Part B2005 May;14(3):139-50.
Kershaw CJ, Ware HE, Pattinson R, Fixsen JA. Revision of failed open reduction of congenital dislocation of the hip. The Journal of bone and joint surgery British volume1993 Sep;75(5):744-9.
Fu M, Xiang S, Zhang Z, Huang G, Liu J, Duan X, Yang Z, Wu P, Liao W. The biomechanical differences of rotational acetabular osteotomy, Chiari osteotomy and shelf procedure in developmental dysplasia of hip. BMC musculoskeletal disorders2014 Feb 21;15:47.
Carr AJ, Jefferson RJ, Benson MK. Joint laxity and hip rotation in normal children and in those with congenital dislocation of the hip. The Journal of bone and joint surgery British volume1993 Jan;75(1):76-8.

Due to technical limitations, the tables are only available as a download in the supplemental files section.

Tables.docx

Download PDF

Version 1

posted

You are reading this older preprint version

Read the latest preprint version →

Collagen I in the hip capsule plays a role in postoperative clinical function in patients with developmental dysplasia of the hip

Status:

Version 1

Abstract

Figures

Intrduction

Methods

Results

Discussion

Conclusions

Declarations

References

Tables

Supplementary Files

Status:

Version 1